Kensey Nash TriActiv Safety With Small Guiding Catheters Is Equal To Control
This article was originally published in The Gray Sheet
Executive Summary
Kensey Nash's TriActiv distal protection system for saphenous vein graft interventions is associated with significantly more in-hospital hemorrhagic/vascular events than controls in the firm's PRIDE trial